A B Federici

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

Alberto Tosetto, Francesco Rodeghiero, Giancarlo Castaman et al. · Journal of Thrombosis and Haemostasis · 2006 · 527 citations · Full text

Medicine, Hematology, Pathology +16

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

Francesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto et al. · Journal of Thrombosis and Haemostasis · 2005 · 357 citations

Medicine, Hematology, Pathology +16

Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

Jeroen Eikenboom, Vincent Marion, Hein Putter et al. · Journal of Thrombosis and Haemostasis · 2006 · 119 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

Jenny Goudemand, I. Scharrer, Erik Berntorp et al. · Journal of Thrombosis and Haemostasis · 2005 · 87 citations · Full text

Medicine, Pharmacokinetics, Hemostasis +13

Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.

A B Federici, John H. Elder, L. De Marco et al. · Journal of Clinical Investigation · 1984 · 83 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17